Overview
Lobbying Costs
20,000€
Financial year: Feb 2023 - Jan 2024
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Bioresolve Ltd
EU Transparency Register
777047545514-57 First registered on 14 Feb 2022
Goals / Remit
Provision of consultancy services to the biopharmaceutical industry, NGO's and Government covering the development of medical counter measures such as vaccines and public health advice on preparedness and response against pandemics, emerging diseases and bioterror threats.
Main EU files targeted
Public health policies concerning preparedness and response against pandemics, emerging diseases and CBRN threats.
-
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Feb 2023 - Jan 2024
Lobbying costs for closed financial year
20,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount Fipra Public health policies and legislation relating to preparedness and response against pandemics, emerging disease and CBRN events 0€ - 10,000€ Emergent Biosolutions Public Health policies and legislation on preparedness and response against pandemics and bioterrorism 0€ - 10,000€ Clients for current financial year
Clients list
Name Emergent Biosolutions Fipra Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Public healthcare platforms and EU structures concerned with public healthcare.
Communication activities
None
Other activities
None declared
Meetings
Meetings
None declared